From: Impact of 18F-FDG PET/CT, CT and EBUS/TBNA on preoperative mediastinal nodal staging of NSCLC
Characteristics | N (%) |
---|---|
No. of patients | 101 |
Male | 83 (82) |
Female | 18 (18) |
Median age, years (range) | 62.0 (29.8–77.7) |
Smoking history | |
Current smoker | 53 (52.5) |
Any history of smoking | 75 (74.3) |
Histopathology | |
Adenocarcinoma | 57 (56.4) |
Adenosquamous carcinoma | 4 (4) |
Squamous cell carcinoma | 38 (37.6) |
Undifferentiated carcinoma | 2 (2) |
Median tumor size, cm (range) | 5.5 (1.3–15) |
Median SUVmax tumor (range) | 11 (2.7–36) |
Median SUVmax lymph nodes (range) | 5 (1.5–19.5) |
Lobar involvementa | |
RUL | 44 (43.6) |
RML | 14 (13.9) |
RLL | 9 (8.9) |
LUL | 31 (30.7) |
LLL | 11 (10.9) |
Clinical stage | |
I | 16 (15.8) |
II | 16 (15.8) |
III | 59 (58.4) |
IV | 10 (9.9) |
Scans/procedures performed | |
18F-FDG PET/CT | 101 (100) |
CT scan | 99 (98) |
EBUS/TBNA | 40 (39.6) |
Mediastinoscopy | 41 (40.6) |
Lymph node biopsy or dissection | 57 (56.4) |